Pharmacists in Clovis, NM Accepting Medicare

32 Pharmacists found. Showing 1 - 20

Xondria Jennifer Self, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E 21st St, Clovis, NM 88101 Phone: 575-762-3851    Fax: 575-762-5698

Dr. Sharon Suan, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3728 N Prince St, Clovis, NM 88101 Phone: 575-769-2389

Brooke Ondov, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3728 N Prince St, Clovis, NM 88101 Phone: 575-769-2389

James Herman, R. PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E 21st St, Clovis, NM 88101 Phone: 575-762-3851

Phuong Viet Tuan Le, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E 21st St, Clovis, NM 88101 Phone: 575-762-3851    Fax: 575-762-5698

Amy Kristine Kelley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3728 N Prince St, Clovis, NM 88101 Phone: 575-769-2389

Britney D'von Hawkins, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 E Llano Estacado Blvd, Clovis, NM 88101 Phone: 575-762-3848    Fax: 575-762-3840

Phuong My Trinh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E 21st St, Clovis, NM 88101 Phone: 575-762-3851

David Michael Lansford, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 E Llano Estacado Blvd, Clovis, NM 88101 Phone: 505-762-3848

Loveta Rae Briscoe Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E 21st St, Clovis, NM 88101 Phone: 575-762-2851

Joseph Raymond Luna Jr., PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 305 E Llano Estacado Blvd, Clovis, NM 88101 Phone: 575-762-3848    Fax: 575-762-3840

Jonathan Wesley Delong, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E 21st St, Clovis, NM 88101 Phone: 575-762-3851

Robert Grzywacz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3728 N. Prince St., Clovis, NM 88101 Phone: 575-769-2389    Fax: 575-769-2495

Andrea Marshall Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3728 N Prince St, Clovis, NM 88101 Phone: 575-769-2389

Kaitlyn Kimball Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E 21st St, Clovis, NM 88101 Phone: 575-762-3851

Amanda Nantais Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 E Llano Estacado Blvd, Clovis, NM 88101 Phone: 269-615-1485

Dr. Trapper Eldridge, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 E. Llano Estacado Blvd, Clovis, NM 88101 Phone: 575-762-3848    Fax: 575-762-3840

Christopher Livesay, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E 21st St, Clovis, NM 88101 Phone: 575-762-3851

Dr. Shem Gichuhi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E 21st St, Clovis, NM 88101 Phone: 575-762-3851

Anica Monique Marez Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2401 W 21st St, Clovis, NM 88101 Phone: 575-799-7792

News Archive

Asuragen reports collaborative study results of advanced PCR-based molecular profiling of FMR1 gene

Asuragen, Inc. announced today the results from two collaborative studies, one with the University of California Davis M.I.N.D. Institute and another with Rush University Medical Center, that demonstrate comprehensive molecular profiling of the Fragile X Mental Retardation (FMR1) gene using advanced PCR-based methods.

Alnylam commences dosing in ALN-TTR02 Phase I clinical trial for TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The study is aimed at evaluating the safety and tolerability of ALN-TTR02 in healthy volunteers.

TTI granted exclusive worldwide rights to commercialize two immunology programs

Trillium Therapeutics Inc., a biopharmaceutical company developing innovative immune-based biologics, today announced that it has entered into two definitive license agreements with University Health Network and The Hospital for Sick Children in Toronto, Ontario, granting Trillium exclusive worldwide rights to commercialize two immunology programs in the areas of hematopoietic stem cell transplantation and cancer.

CIBMTR report shows higher survival rate for patients treated at RPCI's BMT program

Outcomes for patients treated through the Blood and Marrow Transplant Program at Roswell Park Cancer Institute (RPCI) are among the highest in the nation. For the second consecutive year, a report compiled by the Center for International Blood and Marrow Transplant Research (CIBMTR) shows that the one-year survival rate for transplant patients treated at RPCI was significantly higher than expected, affirming RPCI's position among the elite of U.S. centers performing the procedure.

Read more Medical News

› Verified 6 days ago

• 1(current)
• 2